CD19 and acute lymphoblastic leukemia: 2024 Update: FDA clearance for incorporation into consolidation therapy protocols targeting adult and pediatric (≧1month old) patients with Philadelphia chromosome-negative CD19+ B-ALL during multiphase chemotherapy.